Compare Valbiotis SA with Similar Stocks
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
44.0%
0%
44.0%
6 Months
27.11%
0%
27.11%
1 Year
-4.84%
0%
-4.84%
2 Years
-71.66%
0%
-71.66%
3 Years
-74.45%
0%
-74.45%
4 Years
-84.35%
0%
-84.35%
5 Years
-87.09%
0%
-87.09%
Valbiotis SA for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.03%
EBIT Growth (5y)
-14.68%
EBIT to Interest (avg)
-9.71
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.67
Sales to Capital Employed (avg)
0.14
Tax Ratio
7.03%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
0
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
NA
EV to EBIT
-0.92
EV to EBITDA
-0.93
EV to Capital Employed
-0.81
EV to Sales
10.65
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
Negative Capital Employed
ROE (Latest)
NA
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
Bearish
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
0.20
4.70
-95.74%
Operating Profit (PBDIT) excl Other Income
-10.70
-8.60
-24.42%
Interest
0.20
0.20
Exceptional Items
0.00
0.00
Consolidate Net Profit
-10.00
-7.40
-35.14%
Operating Profit Margin (Excl OI)
-64,097.10%
-1,955.60%
-6,214.15%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -95.74% vs 487.50% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -35.14% vs 39.84% in Dec 2023
About Valbiotis SA 
Valbiotis SA
Pharmaceuticals & Biotechnology
Valbiotis SA is a France-based company engaged in the biotechnology industry. The Company specializes in developing nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. It seeks to develop solutions designed to prevent type 2 diabetes, NASH, (non-alcoholic steatohepatitis) and obesity and to offer nutritional support. The Company prevents disease by developing products that reduce the risk factors of irreversible chronic diseases. It provides patient support through new-generation medical nutrition solutions containing patented substances with clinically proven effects. Its products are plant-based and undergo strict scientific and clinical tests in collaboration with academic research centers.
Company Coordinates 
Company Details
12F rue Paul Vatine , PERIGNY None : 17180
Registrar Details






